Filing Details
- Accession Number:
- 0001209191-18-051471
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-09-18 16:27:48
- Reporting Period:
- 2018-09-17
- Accepted Time:
- 2018-09-18 16:27:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1660334 | Verrica Pharmaceuticals Inc. | VRCA | Pharmaceutical Preparations (2834) | 463137900 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1717580 | Linda Palczuk | C/O Verrica Pharmaceuticals Inc. 10 North High Street, Suite 200 West Chester PA 19380 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-09-17 | 2,500 | $16.52 | 5,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $16.52 to $16.55, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
- Consists of 3,000 shares of common stock held by Ms. Palczuk and 2,500 shares of common stock held by Ms. Palczuk jointly with her spouse.